SCD and X-linked adrenoleukodystrophy: While this study identified the importance of SCD1 in preventing the toxic accumulation of saturated VLCFAs, more research is warranted to confirm the therapeutic potential of increasing SCD1 expression in X-ALD and to assess the suitability of LXR agonists to do so.